Meticulous Research®—a leading global market research company, published a research report titled, ‘RWE Analytics Market by Application [Market Access & Reimbursement, Drug Development & Approval (Oncology, Neurology, Cardiovascular), Post Market Surveillance, Medical Device Development], End User (Pharma, Payer, Provider) - Global Forecast to 2029’.
The global real-world evidence (RWE) analytics market is poised to experience robust growth, with a projected CAGR of 15.1% during the forecast period from 2022 to 2029. By 2029, the market is expected to reach a value of $2.93 billion. Key drivers of this growth include the proliferation of big data in the healthcare industry, a shift from volume to value-based care, and an increased focus on personalized healthcare.
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5306
Despite these positive factors, the lack of standardized methodologies to develop RWE may pose a challenge to the market's growth. The global RWE analytics market is segmented by application, end-user, and geography. Applications include market access and reimbursement/coverage decisions, drug development and approvals, post-market surveillance, medical device development and approvals, and clinical and regulatory decision-making.
End-users comprise pharmaceutical, biotechnology, and medical device companies, healthcare payers, healthcare providers, and other end-users. Industry competitors are also evaluated in the study, with their market share analyzed at both global and regional levels.
Overall, the RWE analytics market presents significant opportunities for growth and innovation in the healthcare industry, with the potential to improve patient outcomes and drive value-based care.
Speak to our Analysts: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5306
Scope of the Report
Real-world Evidence Analytics Market, by Application
• Market Access & Reimbursement/Coverage Decisions
• Drug Development & Approvals
o Oncology
o Neurology
o Immunology
o Cardiovascular Diseases
o Other Therapeutic Areas
• Post Market Surveillance
• Medical Device Development & Approvals
• Regulatory and Clinical Decision-making
Real-world Evidence Analytics Market, by End User
• Pharmaceutical, Biotechnology, and Medical Device Companies
• Healthcare Payers
• Healthcare Providers
• Other End Users
(Other end users include academic research institutions, patient advocacy groups, regulators, and health technology assessment agencies)
Quick Buy: https://www.meticulousresearch.com/Checkout/39531640
Key Players- Clinigen Group plc (U.K.), ICON plc (Ireland), IQVIA Holdings Inc. (U.S.), Oracle Corporation (U.S.), Parexel International Corporation (U.S.), PerkinElmer, Inc. (U.S.), PPD Inc. (U.S.), SAS Institute Inc. (U.S.), UnitedHealth Group Incorporated (U.S.), and Flatiron Health (U.S.).
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/real-world-evidence-analytics-market-5306
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research